18th Annual International Congress on Hematologic Malignancies®
Crowne Plaza
New York, NY
February 14 - 15, 2014
 
31st Annual Miami Breast Cancer Conference®
Fontainebleau Miami Beach
Miami Beach, FL
March 6 - 9, 2014
 
7th Annual Interdisciplinary Prostate Cancer Congress™ (IPCC®)
Corwne Plaza 
New York, NY
March 15, 2014
 
13th Annual International Congress on the Future of Breast Cancer®
Hyatt Regency
Huntington Beach, CA
July 17 - 19, 2014
 
15th Annual International Lung Cancer Congress®
Hyatt Regency
Huntington Beach, CA
July 31 - August 2, 2014

12th Annual International Congress on Targeted Therapies in Cancer®
New York, NY
October 2014

12th Annual School of Breast Oncology®
Emory University Conference Center
Atlanta, GA

November 6 - 9, 2014

9th Annual New York Lung Cancer Symposium®
New York
November 8, 2014




Upcoming AJMC events
With the fast moving, ever-changing landscape of healthcare today, the mission of AJMC TV is to inform payers, clinical decision makers, and policy makers through brief video interviews providing the most recent and important information.
Lee Newcomer, MD, MHA, Describes NCCN’s Approach to Genetic Testing
Lee Newcomer, MD, MHA, of Oncology, Genetics and Women's Health for UnitedHealthcare, says the National Comprehensive Cancer Network is transforming genetic testing by utilizing a tool called the NCCN Biomarkers Compendium, which encourages evidence-based decision-making.
 
Edmund J. Pezalla, MD, MPH, Describes Aetna’s Approach to Managing Obesity
Edmund J. Pezalla, MD, MPH, national medical director, Aetna Pharmacy Management, says that Aetna recognizes the implications of the obesity epidemic and how it contributes to a variety of other medical problems such as diabetes and hypertension.
 
Christine Strahl, PharmD, MBA, BCPS, Discusses Channels and Methods for Specialty Pharmacy Distribution
Christine Strahl, PharmD, MBA, BCPS, specialty pharmacy program manager, HealthPartners, says there are several new distribution channels in specialty pharmacy.
Episode 11 – Personalized Medicine in CRPC
During this segment, the panelists review the use of personalized medicine in castration-resistant prostate cancer.